SCHEMBL4351703

SCHEMBL4351703

O=C(NC1=NC(=O)C(=Cc2ccc(C(F)(F)F)cc2)S1)Nc1ccccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.42
TSHR P16473 1/20 0.42
PIM1 P11309 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
ALOX5 P09917 1/20 0.39
POLB P06746 2/20 0.39
MAPK1 P28482 1/20 0.39
GRIK1 P39086 1/20 0.39
NPC1 O15118 1/20 0.39
THRB P10828 1/20 0.39
NOX1 Q9Y5S8 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
PTPN1 P18031 1/20 0.39
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351701 1.00 MEN1 (0.43) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL4351314 0.91 ALDH1A1 (0.47) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL4351318 0.91 ALDH1A1 (0.47) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL4352670 0.85 EPHX2 (0.52) MEN1KMT2AKDM4EALDH1A1PIM1
SCHEMBL4352665 0.85 EPHX2 (0.52) MEN1KMT2AKDM4EALDH1A1PIM1
SCHEMBL4346307 0.80 NPC1 (0.43) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL4352758 0.80 EPHX2 (0.47) MEN1KMT2AKDM4EALDH1A1PIM1
SCHEMBL4352759 0.80 EPHX2 (0.47) MEN1KMT2AKDM4EALDH1A1PIM1
SCHEMBL4634822 0.69 PIM1 (0.41) PIM1PIM2ALOX5PTPN1
SCHEMBL4128685 0.69 PIM1 (0.41) PIM1PIM2ALOX5PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 MEN1 1725/4885KMT2A 3923/4885KDM4E 3224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.